Astena Holdings Co., Ltd.
Financial Summary for the Second Quarter of Fiscal Year 2026 (Ending July 2026) | Net Sales of ¥345.6 billion (+14.8% YoY)
Astena Holdings achieved net sales of ¥345.6 billion (+14.8% YoY) in the second quarter of fiscal year 2026, with increases in operating income and net income. Strong performance in the cosmetics and pharmaceutical segments contributed to steady revenue and profit growth.
Key Figures
- Net sales: ¥345.6 billion (YoY +14.8%)
- Operating income: ¥229.0 billion (YoY +3.2%)
- Net income: ¥141.7 billion (YoY +10.0%)
AI要約
Performance Overview
In the second quarter of fiscal year 2026, Astena Holdings achieved net sales of ¥345.6 billion (up 14.8% YoY), showing steady growth driven by expansion in the cosmetics and pharmaceutical businesses. Operating income increased to ¥229.0 billion (+3.2%), and net income rose to ¥141.7 billion (+10.0%), reflecting overall strong performance. The company is actively promoting new businesses and overseas expansion to strengthen its revenue base.
Future Outlook and Implications for Investors
The company plans to continue expanding sales in cosmetics and pharmaceuticals and aims to grow in overseas markets. Focus will be on acquiring new customers and expanding existing markets, particularly in Asia. These initiatives are expected to support steady full-year performance forecasts, offering investors prospects of stable growth. The company is also proactively investing in capital expenditure and R&D to enhance long-term corporate value.
Astena Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
